Рет қаралды 419
Cettire (CTT) has released a trading update today, reporting sales revenue up 88% for the quarter and adjusted earnings of $6 million on a 20% plus margin. It's also confirmed plans for a launch in China in Q4. Cettire has also reported that the US business is going strong with conversion rates improving, average order values increasing and that growth is profitable. Cettire's shares looked positive off the back of the update but have since dropped by 6%. Our experts, Claude Walker from A Rich Life and Luke Winchester from Merewether Capital, share their views. Claude says the big question is around how they maintain such low prices and combined with the rumoured issues of payment of sales tax in various US states, he says he's not sure if Cettire is company he wants to back. Luke agrees with Claude, pointing out there are a lot of questions raised about how the business is actually achieving the numbers it has with very little capital behind it, as well as around how they actually operate. He has enjoyed watching the debate around this "battleground" stock but would he get involved? Watch to find out if Claude and Luke would buy, hold or sell.
Watch the full episode here: ausbiz.co/4aQDz8b
Stocks covered:
DUR - Duratec
PSI - PSC Insurance
CU6 - Clarity Pharmaceuticals
EXP - ExperienceCo
VNL - Vinyl
IPG - IPD Group
SHG - Singular Health
LBL - Laserbond
WOW - Woolworths
ODA - Orcoda
Trade your Stock of the Day with IG: ausbiz.co/IG_AU
Subscribe to ausbiz:
the COB newsletter - company.ausbiz.com.au/newsletter
ausbiz channel - www.ausbiz.com.au/
Twitter: / ausbiztv
Facebook: / ausbiztv
#asx #sharemarket #stocks #ausbiz #shares #investing #equities #hotstocks #stockpicking